PTGS2 and cancer: In addition, TLR4 stimulates NFκB signal transduction pathway that activates tumor promoting molecules, such as VEGF-A, cyclooxygenase 2 (COX2), interleukins IL-6 and IL-8, and MMP9, which all increase cancer cell survival, immune escape, and increased metastasis (295).